Rajesh L. Email & Phone Number

As a leader, inventor, and entrepreneur, I have dedicated my career to pushing the boundaries of collaborative innovation, accelerating clinical development, and making lasting, transformative impact on patients' lives in the life sciences industry, leveraging cutting-edge technologies, data and statistical sciences, and strategic alliances.Over 2 decades of leadership and hands-on expertise across multiple therapeutic areas, indications, and modalities, including small molecules, biologics, gene therapy, and medical devices, therapeutic areas including oncology, neurology, immunology, nephrology, endocrinology, hematology in clinical development and medical affairs.I bring practical expertise to cross-functional global teams, driving success through persistence, collaboration, innovation, and long-term vision. I'm passionate about building strong relationships, developing talent, and creating a culture of extraordinary excellence.Extensive global experience and a deep understanding of the international regulatory landscape, supporting submissions (IND/NDA/BLA) to various global regulatory agencies, i.e., FDA, EMA, Health Canada, PMDA, and Taiwan. I have experience working with several diverse indications including: Acute Myeloid Leukaemia, Locally advanced or Metastatic Colorectal cancer, Hepatocellular Carcinoma, Chemotherapy Induced Neutropenia & Peripheral Blood Progenitor Cell in Breast Cancer (stage I to IV), Small Cell Lung Cancer, Non-small Cell Lung Cancer, Non-Hodgkin’s Lymphoma, Pediatric Sarcoma, Metastatic Colon Cancer, Ovarian Cancer, Oral Mucositis and Dysphagia in hematologic malignancies, IgA Nephropathy, and molecular alterations targeted therapy trials in advanced solid tumors including PIK3CA, ALK, PTEN, AKT, PD-L1, HER2, ROS1, EGFR, BRAF, HHOG, DLL3. Skilled in developing and executing business strategies, driving revenue growth, strategic acquisitions, mergers, and divestitures of biotech products/organizations involving transition and consolidation of systems, processes, IP, and data. During my career, I witnessed the rapid growth of clinical trials complexity, outpacing the innovation in existing analytics solutions. Recognizing this gap, I leveraged my extensive experience to launch MLytics Life Sciences. Our mission is to disrupt the clinical trial analytics model by harnessing the power of the MLytics Studio platform.#ClinicalResearch #Innovation #Disruption #AI #ML #TransformingClinicalTrials #MLyticsLifeSciences